Lachmann et al., 1981 - Google Patents
The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand.Lachmann et al., 1981
View PDF- Document ID
- 10647171326945396162
- Author
- Lachmann P
- Vyakarnam A
- Sikora K
- Publication year
- Publication venue
- Immunology
External Links
Snippet
The introduction of an antigenic determinant strongly recognized by T cells on to a cell enhances the immune response to weak cellular antigens. Tuberculin (PPD) is a particularly suitable antigenic determinant for this purpose since it behaves in many ways as a'T-cell …
- 101700036312 CONA 0 title abstract description 93
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
- A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4478823A (en) | Immunological preparations containing purified MHC antigens bonded to other antigens | |
| Johansson et al. | Immunological studies of an atypical (myeloma) immunoglobulin | |
| US4371515A (en) | Method for forming an isolated lectin-immunological conjugate | |
| EP0180564B1 (en) | Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents | |
| US4400376A (en) | Immunological preparations | |
| Coligan et al. | Structure of the streptococcal groups A, A-variant and C carbohydrates | |
| Möller et al. | Role of C'3 and Fc receptors in B-lymphocyte activation. | |
| EP0091760B1 (en) | Anti immune complex antibody and preparation thereof | |
| US4123427A (en) | Method for the purification of mycobacterial protein antigens and resulting product | |
| Springer et al. | Properties and activity of the lipopolysaccharide-receptor from human erythrocytes | |
| Van Es et al. | Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes | |
| Bray et al. | Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes. | |
| Thomson et al. | Isolation of human tumour-specific antigens associated with β2 microglobulin | |
| Anundi et al. | Subunit structure of thymus leukemia antigens | |
| Natori et al. | Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, Meth-A | |
| Medgyesi et al. | Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. | |
| Peacock et al. | Rapid fluorescent-antibody conjugation procedure | |
| US5603932A (en) | Receptor of the minor human rhinovirus receptor group | |
| Lachmann et al. | The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand. | |
| KR870001375B1 (en) | Process for preparing glycosidic linkage related antigen | |
| Gheţie et al. | Multivalent hybrid antibody | |
| Carlsson et al. | Antibody‐induced destruction of colon antigen‐coated chicken erythrocytes by normal human lymphocytes | |
| Robbins et al. | [90] Immunoadsorbents | |
| Lisowska et al. | Specific Antibodies for Desialized M and N Blood group Antigens 1 | |
| Pereira et al. | A versatile immunoadsorbent capable of binding lectins of various specificities and its use for the separation of cell populations. |